Analyses based on data from TCGA, Rembrandt, GSE16011, and CGGA datasets consistently indicated a noticeable increase in IL4I1 levels with higher tumor grades, particularly in WHO grade IV compared with grades II and III (Figures 4A–D). The gene discussed is IL4I1; the disease is neoplasm.